Figure 2: A. BSA fluorescence spectra in the presence of olanzapine, λex= 280 nm, CBSA= 2x10-5 mol L-1 ; molar ratio of drug (olan) to protein (BSA) is 0, 1, 2, 4, 6, 9, 12, 16 μM [from (a to h)] at 298 K , pH=7.40 . B. BSA fluorescenc spectra in the presence of olanzapine, λex= 280 nm, CBSA= 2x10-5 mol L-1 ; molar ratio of drug to protein is 0, 1, 2, 4, 6, 9, 12, 16 μM [from (a to h)] at 308 K , pH=7.40. C. BSA fluorescenc spectra in the presence of olanzapine, λex= 293 nm, CBSA= 2x10-5 mol L-1 ; molar ratio of drug to protein is 0, 1, 2, 4, 6, 9, 12, 16 μM [from (a to h)] at 298 K , pH=7.40. D. BSA fluorescenc spectra in the presence of olanzapine, λex= 293 nm, CBSA= 2x10-5 mol L-1 ; molar ratio of drug to protein is 0, 1, 2, 4, 6, 9, 12, 16 μM [from (a to h)] at 308 K , pH=7.40.